AUA Annual Meeting Expected Draw Some 16,000 Attendees
Researchers are scheduled to present more than 2500 studies at the American Urological Association 2018 annual meeting in San Francisco.
Approximately 16,000 people from more than 100 countries are expected to attend the American Urological Association's 2018 annual meeting, which is being held in San Francisco from May 18 to 21. Investigators from around the world will present more than 2500 poster, podium, and video sessions detailing new study findings and advances in diagnostic and surgical technique.
The conference will offer attendees more than 50 hours of plenary programming and 80 instructional courses. Key programs include Crossfire: Controversies in Urology, Second Opinion Cases, Surgical Techniques: Tips and Tricks, and Court is in Session.
As in previous years, the 2018 scientific program will feature numerous symposia and presentations on timely topics in urology. Aria Olumi, MD, Chair of Research for the AUA and Chief of Urology at Beth Israel Deaconess Medical Center in Boston and Professor of Surgery at Harvard Medical School, offered what he considers some of the notable sessions. Among them is the “Urologic Oncology Research Symposium: Tumor Microenvironment and Immunology: Frontiers in Cancer Therapy” (May 18, 7:30 a.m. to 5 p.m., MCC South, 208). The speakers are Allan Pantuck, MD, of the UCLA Institute of Urologic Oncology and William Dahut, MD, of the Center for Cancer Research at the National Cancer Institute in Bethesda, Maryland. Another noteworthy session is a “Next Frontier” plenary session titled “Prostate Cancer Screening, Diagnosis and Treatment in Gay, Bisexual, and Transgender Population” (May 21, 9:00 to 9:30, MCC North, Hall E). The session will be a panel discussion by Dr Olumi and B.R. Simon Rosser, PhD, MPH, of the University of Minnesota in Minneapolis.
Dr Olumi also emphasized that this year's meeting will feature state-of-the-art talks on biomarkers for urinary cancers and faculty discussions about such controversial issues as gender reassignment surgery for younger patients.